Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Depression: Overview01:18

Depression: Overview

229
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
229
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

59
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
59
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

401
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
401
Cognitive Therapy01:25

Cognitive Therapy

148
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
148
Long-term Depression01:05

Long-term Depression

30.7K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
30.7K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

The Lateral Habenula to Ventral Tegmental Area Pathway is Required for Aversive Learning and Defensive Behaviors.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

Review: "The Disappointment Dilemma: Short- and Long-Term Learning From Negative Outcomes".

The European journal of neuroscience·2026
Same author

Transcriptional Profiling of the Cortico-Accumbal Pathway Reveals Sex-Specific Alterations Underlying Stress Susceptibility.

Biological psychiatry·2025
Same author

Chronic Social Defeat Stress Induces Pathway-Specific Adaptations at Lateral Habenula Neuronal Outputs.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2024
Same author

Hypothalamic neuronal outputs transmit sensorimotor signals at the onset of locomotor initiation.

iScience·2023
Same author

A novel role for the lateral habenula in fear learning.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2022
Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026
Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026
Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026
Same journal

Retraction.

Science (New York, N.Y.)·2026
Same journal

Making time.

Science (New York, N.Y.)·2026
関連記事をすべて見る

関連する実験動画

Updated: Jun 17, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.5K

うつ病を抑える

Jose Cesar Hernandez Silva1, Christophe D Proulx1

  • 1Universite Laval, Quebec City, Quebec, Canada.

Science (New York, N.Y.)
|August 8, 2024
PubMed
まとめ
この要約は機械生成です。

ケタミンは抗うつ剤で 特定の神経受容体を阻害します これは脳の過剰活動領域を標的とし 鬱病の治療に 新しいアプローチを提示します

さらに関連する動画

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.2K
The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

37.2K

関連する実験動画

Last Updated: Jun 17, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.5K
Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.2K
The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

37.2K

科学分野:

  • 神経科学
  • 薬理学について

背景:

  • うつ病は 脳の特定の領域の 過剰活動と関連しています
  • 既存の抗うつ薬の有効性や副作用のプロフィールには 限界があります

研究 の 目的:

  • 抗うつ剤としてのケタミン作用のメカニズムを調査する
  • ケタミンの標的となる特定の神経受容体と脳の領域を特定する

主な方法:

  • 神経画像技術を使って 脳の活動を観察した
  • ケタミン投与と神経受容体阻害のモニタリング
  • ケタミンの反応による 神経活動の変化を分析した.

主要な成果:

  • ケタミンは神経受容体を 効果的に阻害することが判明しました
  • この阻害は 鬱と関連した脳領域に 集中していました
  • 脳の特定の領域における 過剰活動性の減少が観察されました

結論:

  • ケタミンの抗うつ効果は 過剰活動性の脳回路にある神経受容体を 阻害することによって引き起こされます
  • このメカニズムは 治療に抵抗するうつ病に対する 新しい治療戦略を提供します